Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Ai Zheng ; 28(12): 1328-32, 2009 Dec.
Artigo em Chinês | MEDLINE | ID: mdl-19958630

RESUMO

BACKGROUND AND OBJECTIVE: B7-H1, a member of B7 family, is expressed in tumor cells and has emerged as an important immune modulator capable of suppressing host immunity by inhibiting T cells function. This study was to probe into the correlation between the expression level of B7-H1 protein in pancreatic carcinoma tissues and clinicopathological characteristics and prognosis. METHODS: The expression of B7-H1 was measured in 40 cases of pancreatic carcinoma tissues and 10 cases of normal corresponding paracarcinoma tissues by immunohistochemistry. The relationship between the expression level of B7-H1 and clinicopathological characteristics and survival was analyzed. RESULTS: The positive rate of B7-H1 was significantly higher in the tumor tissues [45.00% (18/40)] than in the normal corresponding paracarcinoma tissues [0(0/10)] (P<0.05); moreover, B7-H1 expression was significantly associated with the staging of tumor and preoperative serum CA19-9 level (P<0.05). The multivariate cox proportional hazards regression analysis of prognostic factors for overall survival and relapse-free survival showed that the expression of B7-H1 was an independent factor for poor prognosis. CONCLUSION: B7-H1 protein was expressed in human pancreatic carcinoma tissues, and was associated with the prognosis.


Assuntos
Antígenos CD/metabolismo , Carcinoma Ductal/metabolismo , Neoplasias Pancreáticas/metabolismo , Adulto , Idoso , Antígeno B7-H1 , Antígeno CA-19-9/sangue , Carcinoma Ductal/sangue , Carcinoma Ductal/tratamento farmacológico , Carcinoma Ductal/patologia , Carcinoma Ductal/cirurgia , Quimioterapia Adjuvante , Cistadenocarcinoma Mucinoso/sangue , Cistadenocarcinoma Mucinoso/tratamento farmacológico , Cistadenocarcinoma Mucinoso/metabolismo , Cistadenocarcinoma Mucinoso/patologia , Cistadenocarcinoma Mucinoso/cirurgia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Pancreatectomia/métodos , Neoplasias Pancreáticas/sangue , Neoplasias Pancreáticas/tratamento farmacológico , Neoplasias Pancreáticas/patologia , Neoplasias Pancreáticas/cirurgia , Prognóstico , Modelos de Riscos Proporcionais
2.
Ai Zheng ; 28(7): 679-84, 2009 Jul.
Artigo em Chinês | MEDLINE | ID: mdl-19624891

RESUMO

BACKGROUND AND OBJECTIVE: Protein 4.1, a component of cell membrane skeleton, plays a role in maintaining the shape and mechanical stability of erythrocytes. Recent researches showed that protein 4.1 may be associated with the development of tumors. This study was to investigate the expression and significance of membrane skeleton protein 4.1 family members (4.1B, 4.1R, 4.1N and 4.1G) in human non-small cell lung cancer (NSCLC). METHODS: The expression of proteins 4.1B, 4.1R, 4.1N and 4.1G in 147 specimens of NSCLC was detected by EnVision plus immunohistochemistry. The correlations of 4.1B, 4.1R, 4.1N and 4.1G expression to clinicopathologic features of NSCLC were analyzed by Wilcoxon rank sum test and Spearman rank correlation analysis. RESULTS: The protein levels of 4.1B, 4.1R and 4.1N were significantly lower in lung squamous cell carcinoma tissues than in adjacent normal tissues (P<0.01). The protein levels of 4.1B, 4.1R, 4.1N and 4.1G were significantly lower in lung adenocarcinoma tissues than in adjacent normal tissues (P<0.05). The protein levels of 4.1B and 4.1G were significantly lower in lung squamous cell carcinoma tissues than in lung adenocarcinoma tissues (P<0.05). Protein 4.1G expression in squamous cell carcinoma was positively correlated to tumor cell differentiation (rs=0.386,P<0.01). In adenocarcinoma, the expression of proteins 4.1B, 4.1N and 4.1G were positively correlated to tumor cell differentiation (rs=0.276, P<0.05; rs=0.248,P<0.05; rs=0.268, P <0.05). The expression of protein 4.1s in squamous cell carcinoma and adenocarcinoma were not related to lymph node metastasis, tumor size, patients'age and sex (P>0.05). CONCLUSIONS: Protein 4.1s are weakly expressed in NSCLC tissues than in adjacent normal tissues. The expression of proteins 4.1B, 4.1N and 4.1G are related to tumor cell differentiation.


Assuntos
Carcinoma Pulmonar de Células não Pequenas/metabolismo , Diferenciação Celular , Proteínas do Citoesqueleto/metabolismo , Neoplasias Pulmonares/metabolismo , Proteínas de Membrana/metabolismo , Adenocarcinoma/metabolismo , Adenocarcinoma/patologia , Adulto , Idoso , Carcinoma Pulmonar de Células não Pequenas/patologia , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/patologia , Feminino , Humanos , Pulmão/metabolismo , Neoplasias Pulmonares/patologia , Metástase Linfática , Masculino , Pessoa de Meia-Idade , Carga Tumoral
3.
Cancer Lett ; 284(1): 55-61, 2009 Oct 18.
Artigo em Inglês | MEDLINE | ID: mdl-19423214

RESUMO

Cyclooxygenase-2 (COX-2) has been found to be over-expressed in esophageal carcinoma (EC) and it could be considered as a potential tumor-associated antigen (TAA). In the present study, six candidate peptides from COX-2 were firstly predicted and synthesized. Among them, P(479) had the highest affinity and stability toward both HLA-A *0201 and HLA-A *03 molecules and it could significantly promote the IFN-gamma release. The cytotoxic T lymphocytes (CTLs) induced by P(479) could specifically lyse COX-2-expressed EC cell lines, EC-1 (HLA-A3 supertype) and EC-9706 (HLA-A2 supertype). These results suggested that P(479) as a novel broad-spectrum T cell epitope would be very useful in immunotherapy against esophageal carcinoma.


Assuntos
Antígenos de Neoplasias/biossíntese , Linfócitos T CD8-Positivos/imunologia , Ciclo-Oxigenase 2/biossíntese , Citotoxicidade Imunológica , Neoplasias Esofágicas/imunologia , Oligopeptídeos/farmacologia , Antígenos de Neoplasias/imunologia , Linhagem Celular Tumoral , Ciclo-Oxigenase 2/imunologia , Epitopos de Linfócito T , Neoplasias Esofágicas/patologia , Antígenos HLA-A/imunologia , Antígeno HLA-A2 , Antígeno HLA-A3 , Humanos , Interferon gama/biossíntese , Oligopeptídeos/síntese química , Oligopeptídeos/imunologia
4.
Artigo em Chinês | MEDLINE | ID: mdl-21180075

RESUMO

AIM: To study the regulation effects of Momordica saponins on endocrine function in senile mice. METHODS: 15-month Kunming mice (female), were divided into senile control group (SC), experimental group 1 and 2 (E1 and E2). 10 4-month mice were as young control group (YC). All mice were fed with general foodstuff, SC and YC drank tap water, while two experimental groups drank tap water supplied to 100 mg/L and 200 mg/L Momordica saponins respectively. Serum was assayed after 5 weeks. At the same time, levels of estrogen receptor and its mRNA were assayed in cultured thymocyte from 12-month rat. RESULTS: Serum ACTH and estradiol levels declined markedly in senile mice compared with young mice. ACTH levels increased in some extent in two experimental groups, while there had significant difference only in E2. Serum estradiol increased obviously, but there was no significant distinct between E1 and E2. The most important was that ER levels increased obviously, and there was no any change of ER mRNA levels in rat thymocyte cultured in medium contained different content of Momordica saponins. CONCLUSION: Momordica saponins could improve endocrine function in senile mice by increasing ACTH level and expression of ER.


Assuntos
Envelhecimento/efeitos dos fármacos , Saponinas/farmacologia , Timócitos/efeitos dos fármacos , Timócitos/metabolismo , Hormônio Adrenocorticotrópico/metabolismo , Animais , Feminino , Camundongos , Camundongos Endogâmicos , Momordica/química , Receptores de Estrogênio/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA